Crystagen
Peptide bioregulator developed by Vladimir Khavinson targeting connective tissue tissue. Studied for organ-specific gene expression normalisation and
Anti-AgingRecovery
● In Stock
Buy more, save more
—
1+ vials
−5%
3+ vials
−10%
5+ vials
−20%
10+ vials
Total Price
$130
For research & laboratory use only. Not for human consumption.
Administration Route
Subcutaneous injection
Ocular Peptide
Khavinson tetrapeptide targeting lens crystallin proteins
Cataract Prevention
May slow age-related protein aggregation in the lens
Retinal Protection
Supports retinal pigment epithelium health in ageing
Effect Profile
Based on primary research mechanisms
Cellular Longevity
0%
Collagen Synthesis
0%
Oxidative Protection
0%
Energy Restoration
0%
Mechanism of Action
Crystagen is a short peptide bioregulator from the Khavinson series, designed to act as a complementary DNA sequence that penetrates cell nuclei and binds to gene promoter regions controlling connective tissue cell proliferation, collagen organisation, and ligament and tendon maintenance. By interacting with nuclear chromatin, it normalises the expression of genes involved in cell cycle regulation and tissue homeostasis, correcting age-associated downregulation of maintenance programmes in the target tissue.
Scientific Research
1
Peptide regulation of aging in connective tissue tissue and anti-aging bioregulators
Annals of the New York Academy of Sciences (2005)